Sarepta Therapeutics Inc.

In News

Sarepta Therapeutics Announces Fourth Quarter and Full-Year 2025 Financial Results and Recent Corporate Developments - Sarepta Therapeutics

Sarepta Therapeutics - Feb 25, 2026

Sarepta Therapeutics (SRPT) Reports Next Week: Wall Street Expects Earnings Growth - Yahoo Finance

Yahoo Finance - Apr 29, 2026

Sarepta says to ‘exercise prudence’ in setting expectations for Elevidys’ recovery - BioSpace

BioSpace - May 07, 2026

Sarepta Therapeutics, Inc. 2026 Q1 - Results - Earnings Call Presentation (NASDAQ:SRPT) 2026-05-06 - Seeking Alpha

Seeking Alpha - May 06, 2026

Sarepta Therapeutics shares rise on early promise for rare disease drugs - statnews.com

statnews.com - Mar 25, 2026

Sarepta Therapeutics Announces First Quarter 2026 Financial Results and Recent Corporate Developments - Business Wire

Business Wire - May 06, 2026

Sarepta Therapeutics Announces Approval of Clinical Trial Application for SRP-1005, Its Investigational Treatment for Huntington’s Disease - Sarepta Therapeutics

Sarepta Therapeutics - Feb 04, 2026

Sarepta Therapeutics, Inc. Q1 2026 Earnings Call Summary - Yahoo Finance

Yahoo Finance - May 07, 2026

Sarepta Therapeutics: A $2B Business Priced Like It’s Broken (NASDAQ:SRPT) - Seeking Alpha

Seeking Alpha - Mar 24, 2026

Sarepta Therapeutics Announces Third Quarter 2025 Financial Results and Recent Corporate Developments, Including Completion of Its Confirmatory Study, ESSENCE - Sarepta Therapeutics

Sarepta Therapeutics - Nov 03, 2025

Sarepta Therapeutics, Inc. (SRPT): A Bull Case Theory - Yahoo Finance

Yahoo Finance - Feb 28, 2026

Sarepta Announces First Clinical Data from siRNA Pipeline Targeting FSHD1 and DM1 - Sarepta Therapeutics

Sarepta Therapeutics - Mar 25, 2026

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment